Share chart Surmodics, Inc.
Extended chart
Simple chart
About
Surmodics, Inc. вместе со своими дочерними компаниями предоставляет технологии модификации поверхности для внутрисосудистых медицинских устройств, а также химические компоненты для диагностических иммуноанализа in vitro и микрочипов в США и за рубежом. Компания работает в двух сегментах: медицинское оборудование и диагностика in vitro. more detailsEBITDA | 0.0103 |
---|---|
EV/EBITDA | 57.01 |
IPO date | 1998-03-04 |
ISIN | US8688731004 |
Industry | Health Care Equipment & Supplies |
P/BV | 5.06 |
P/E | 81.58 |
P/S | 6.19 |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Выручка | 0.1001 |
Див.доход ао | 0 |
Сайт | https://www.surmodics.com |
Цена ао | 42.1 |
Число акций ао | 0.01403 млрд |
Change price per day: | 0% (39.68) |
---|---|
Change price per week: | -0.5763% (39.91) |
Change price per month: | +0.2527% (39.58) |
Change price per 3 month: | +3.15% (38.47) |
Change price per half year: | -5.3% (41.9) |
Change price per year: | +7.45% (36.93) |
Change price per 3 year: | -17.69% (48.21) |
Change price per 5 year: | -4.59% (41.59) |
Change price per 10 year: | 0% (39.68) |
Change price per year to date: | -0.1761% (39.75) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Transaction date | Date of disclosure | Insider | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
---|---|---|---|---|---|---|---|---|---|
05.02.2024 | 07.02.2024 | KNIGHT SUSAN E Director |
Purchase | 23.95 | 94 171 | 3932 | 0 | 0.03 | link |
Institutions | Volume | Share, % |
---|---|---|
Trigran Investments Inc | 2358300 | 16.57 |
Morgan Stanley | 1241793 | 8.72 |
Blackrock Inc. | 1080288 | 7.59 |
Vanguard Group Inc | 859287 | 6.04 |
Soleus Capital Management, L.P. | 771700 | 5.42 |
Millennium Management LLC | 671551 | 4.72 |
Disciplined Growth Investors, Inc. | 614891 | 4.32 |
Renaissance Technologies, LLC | 584138 | 4.1 |
Royce & Associates LP | 420412 | 2.95 |
Segall Bryant & Hamill, LLC | 404170 | 2.84 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Gary R. Maharaj | CEO, President & Director | 1.33M | 1963 (62 years) |
Mr. Timothy J. Arens | Senior VP of Finance & Information Technology and CFO | 645.3k | 1967 (58 years) |
Ms. Teryl L. W. Sides | Senior VP & President of Vascular Interventions | 744.38k | 1970 (55 years) |
Mr. Joseph J. Stich | Senior VP of Human Resources & President of In Vitro Diagnostics | 570.92k | 1965 (60 years) |
Mr. John D. Manders | Corporate Controller, VP of Finance & Principal Accounting Officer | N/A | 1981 (44 years) |
Mr. Charles W. Olson | Senior VP & President of Medical Device Coatings | 618.47k | 1964 (61 year) |
Mr. Gordon S. Weber J.D. | Senior VP of Legal, General Counsel & Secretary | 1964 (61 year) | |
Joel Suiter | Director of Corporate Development |
Address: United States, Eden Prairie, MN -, 9924 West 74th Street - open in Google maps, open in Yandex maps
Website: https://www.surmodics.com
Website: https://www.surmodics.com